Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    18387950 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Available Post Study Continuation of C7 for G1D
Conditions: Glut1 Deficiency Syndrome;   Glucose Transporter Type 1 Deficiency Syndrome
Intervention: Drug: Triheptanoin
2 Recruiting The Glucose Transporter Type I Deficiency (G1D) Registry
Conditions: GLUT1 Deficiency Syndrome;   Glucose Transporter Type 1 Deficiency Syndrome;   Glucose Transporter type1 (GLUT-1) Deficiency;   GLUT-1 Deficiency Syndrome
Intervention: Other: No intervention
3 Not yet recruiting Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D)
Conditions: Glucose Transporter Type 1 Deficiency Syndrome;   Glut1 Deficiency Syndrome
Intervention: Drug: Triheptanoin
4 Active, not recruiting Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)
Conditions: Glucose Transporter Type 1 Deficiency Syndrome;   GLUT1 Deficiency Syndrome
Intervention: Drug: Triheptanoin

Indicates status has not been verified in more than two years